End-of-day quote
Korea S.E.
18:00:00 2024-05-16 EDT
|
5-day change
|
1st Jan Change
|
5,350
KRW
|
+0.56%
|
|
+0.94%
|
-33.87%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
46,062
|
38,057
|
30,895
|
52,031
|
47,045
|
55,126
|
Enterprise Value (EV)
1 |
50,034
|
40,874
|
32,421
|
55,104
|
47,057
|
58,734
|
P/E ratio
|
-14.7
x
|
-30.5
x
|
77.2
x
|
19.2
x
|
14.5
x
|
-20.7
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
1.79
x
|
1.31
x
|
1.06
x
|
1.47
x
|
1.33
x
|
2.02
x
|
EV / Revenue
|
1.95
x
|
1.41
x
|
1.11
x
|
1.56
x
|
1.33
x
|
2.15
x
|
EV / EBITDA
|
248
x
|
20.8
x
|
6.31
x
|
10.8
x
|
7.62
x
|
53.5
x
|
EV / FCF
|
263
x
|
64.2
x
|
14.8
x
|
-27.9
x
|
43
x
|
900
x
|
FCF Yield
|
0.38%
|
1.56%
|
6.74%
|
-3.58%
|
2.32%
|
0.11%
|
Price to Book
|
1.53
x
|
1.33
x
|
1.06
x
|
1.64
x
|
1.35
x
|
1.5
x
|
Nbr of stocks (in thousands)
|
7,022
|
7,022
|
7,022
|
7,022
|
7,022
|
6,814
|
Reference price
2 |
6,560
|
5,420
|
4,400
|
7,410
|
6,700
|
8,090
|
Announcement Date
|
19-03-01
|
20-02-29
|
21-03-01
|
22-03-01
|
23-03-01
|
24-02-29
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
25,711
|
29,042
|
29,117
|
35,296
|
35,306
|
27,349
|
EBITDA
1 |
202.1
|
1,969
|
5,137
|
5,103
|
6,176
|
1,099
|
EBIT
1 |
-3,409
|
-1,540
|
1,701
|
2,002
|
2,941
|
-2,134
|
Operating Margin
|
-13.26%
|
-5.3%
|
5.84%
|
5.67%
|
8.33%
|
-7.8%
|
Earnings before Tax (EBT)
1 |
-3,131
|
-1,248
|
400.1
|
2,712
|
3,250
|
-2,626
|
Net income
1 |
-3,131
|
-1,248
|
400.1
|
2,712
|
3,250
|
-2,688
|
Net margin
|
-12.18%
|
-4.3%
|
1.37%
|
7.68%
|
9.2%
|
-9.83%
|
EPS
2 |
-445.9
|
-177.7
|
56.98
|
386.2
|
462.8
|
-391.3
|
Free Cash Flow
1 |
190.1
|
637
|
2,186
|
-1,975
|
1,094
|
65.26
|
FCF margin
|
0.74%
|
2.19%
|
7.51%
|
-5.6%
|
3.1%
|
0.24%
|
FCF Conversion (EBITDA)
|
94.09%
|
32.34%
|
42.55%
|
-
|
17.71%
|
5.94%
|
FCF Conversion (Net income)
|
-
|
-
|
546.35%
|
-
|
33.66%
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
19-03-01
|
20-02-29
|
21-03-01
|
22-03-01
|
23-03-01
|
24-02-29
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
3,972
|
2,817
|
1,525
|
3,074
|
12
|
3,608
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
19.66
x
|
1.43
x
|
0.2969
x
|
0.6024
x
|
0.001944
x
|
3.283
x
|
Free Cash Flow
1 |
190
|
637
|
2,186
|
-1,975
|
1,094
|
65.3
|
ROE (net income / shareholders' equity)
|
-9.91%
|
-4.25%
|
1.38%
|
8.9%
|
9.74%
|
-7.57%
|
ROA (Net income/ Total Assets)
|
-3.87%
|
-1.86%
|
2.21%
|
2.58%
|
3.44%
|
-2.34%
|
Assets
1 |
80,840
|
66,973
|
18,120
|
105,120
|
94,366
|
115,056
|
Book Value Per Share
2 |
4,278
|
4,089
|
4,156
|
4,524
|
4,978
|
5,380
|
Cash Flow per Share
2 |
869.0
|
953.0
|
708.0
|
805.0
|
692.0
|
700.0
|
Capex
1 |
592
|
868
|
2,172
|
4,703
|
5,622
|
678
|
Capex / Sales
|
2.3%
|
2.99%
|
7.46%
|
13.32%
|
15.92%
|
2.48%
|
Announcement Date
|
19-03-01
|
20-02-29
|
21-03-01
|
22-03-01
|
23-03-01
|
24-02-29
|
|
1st Jan change
|
Capi.
|
---|
| -33.87% | 26.91M | | +5.41% | 105B | | -3.11% | 64.71B | | +73.33% | 49.72B | | +17.24% | 38.6B | | +6.13% | 32.54B | | +12.77% | 19.94B | | +15.03% | 16.92B | | +19.06% | 15.2B | | +6.28% | 14.39B |
Other Commodity Chemicals
|